However, some reports have shown that SARS-CoV-2 infection unexpectedly caused mild clinical manifestations in pwCF, suggesting that CFTR expression and function, or pharmacological treatments such as CFTR modulators might be involved and, in some way, influence the pathophysiology of COVID-19. This evidence concerns the gene CFTR and COVID-19.